Effects of Marine Phospholipids Extract on the Lipid Levels of Metastatic and Nonmetastatic Prostate Cancer Patients

Table 2

Blood parameters in the study population before and after MPL supplementation.

Blood parameter	Before MPL	After MPL*
Albumin (g/dL)	4.1 (2.8–5)	4.3 (2.6–5)	<0.001
Erythrocytes (Mio/L)	4.2 (2.7–5.7)	4.6 (2.8–5.7)	<0.001
Haematocrit (%)	38.7 (22.7–50.3)	41.9 (24.7–50.3)	<0.001
CRP (mg/L)	12 (0.7–260)	2 (0.7–305)	<0.001
PSA (g/L)	2.3 (0–1085)	0.4 (0–1117)	<0.001
Thrombocytes (1000/L)	219 (27–481)	218 (99–484)	n.s.
Leucocytes (1000/L)	7.2 (3.2–16.4)	6.3 (2.8–24.1)	<0.001
CHE (U/L)	7419 (2185–13950)	8221 (3959–12635)	<0.001
AST (U/L)	28.5 (9–316)	28 (16–79)	n.s.
ALT (U/L)	26 (5–170)	26 (6–120)	n.s.

*Most patients underwent surgery shortly before MPL intervention.